Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

567 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effects of dietary fat modification on oxidative stress and inflammatory markers in the LIPGENE study.
Petersson H, Risérus U, McMonagle J, Gulseth HL, Tierney AC, Morange S, Helal O, Shaw DI, Ruano JA, López-Miranda J, Kieć-Wilk B, Gołąbek I, Blaak EE, Saris WH, Drevon CA, Lovegrove JA, Roche HM, Basu S. Petersson H, et al. Among authors: saris wh. Br J Nutr. 2010 Nov;104(9):1357-62. doi: 10.1017/S000711451000228X. Epub 2010 Jun 23. Br J Nutr. 2010. PMID: 20569506 Clinical Trial.
LIPGENE food-exchange model for alteration of dietary fat quantity and quality in free-living participants from eight European countries.
Shaw DI, Tierney AC, McCarthy S, Upritchard J, Vermunt S, Gulseth HL, Drevon CA, Blaak EE, Saris WH, Karlström B, Helal O, Defoort C, Gallego R, López-Miranda J, Siedlecka D, Malczewska-Malec M, Roche HM, Lovegrove JA. Shaw DI, et al. Among authors: saris wh. Br J Nutr. 2009 Mar;101(5):750-9. doi: 10.1017/S0007114508039962. Epub 2008 Aug 5. Br J Nutr. 2009. PMID: 18680629 Clinical Trial.
Impact of geographical region on urinary metabolomic and plasma fatty acid profiles in subjects with the metabolic syndrome across Europe: the LIPGENE study.
Walsh MC, McLoughlin GA, Roche HM, Ferguson JF, Drevon CA, Saris WH, Lovegrove JA, Risérus U, López-Miranda J, Defoort C, Kieć-Wilk B, Brennan L, Gibney MJ. Walsh MC, et al. Among authors: saris wh. Br J Nutr. 2014 Feb;111(3):424-31. doi: 10.1017/S0007114513002602. Epub 2013 Sep 19. Br J Nutr. 2014. PMID: 24047691
A gene variation (rs12691) in the CCAT/enhancer binding protein α modulates glucose metabolism in metabolic syndrome.
Delgado-Lista J, Perez-Martinez P, Garcia-Rios A, Phillips CM, Hall W, Gjelstad IM, Lairon D, Saris W, Kieć-Wilk B, Karlström B, Drevon CA, Defoort C, Blaak EE, Dembinska-Kieć A, Risérus U, Lovegrove JA, Roche HM, Lopez-Miranda J. Delgado-Lista J, et al. Nutr Metab Cardiovasc Dis. 2013 May;23(5):417-23. doi: 10.1016/j.numecd.2011.09.008. Epub 2012 Jan 23. Nutr Metab Cardiovasc Dis. 2013. PMID: 22269963 Clinical Trial.
APOE genotype influences insulin resistance, apolipoprotein CII and CIII according to plasma fatty acid profile in the Metabolic Syndrome.
Fallaize R, Carvalho-Wells AL, Tierney AC, Marin C, Kieć-Wilk B, Dembińska-Kieć A, Drevon CA, DeFoort C, Lopez-Miranda J, Risérus U, Saris WH, Blaak EE, Roche HM, Lovegrove JA. Fallaize R, et al. Among authors: saris wh. Sci Rep. 2017 Jul 24;7(1):6274. doi: 10.1038/s41598-017-05802-2. Sci Rep. 2017. PMID: 28740125 Free PMC article. Clinical Trial.
Effect of the interaction between diet composition and the PPM1K genetic variant on insulin resistance and β cell function markers during weight loss: results from the Nutrient Gene Interactions in Human Obesity: implications for dietary guidelines (NUGENOB) randomized trial.
Goni L, Qi L, Cuervo M, Milagro FI, Saris WH, MacDonald IA, Langin D, Astrup A, Arner P, Oppert JM, Svendstrup M, Blaak EE, Sørensen TI, Hansen T, Martínez JA. Goni L, et al. Among authors: saris wh. Am J Clin Nutr. 2017 Sep;106(3):902-908. doi: 10.3945/ajcn.117.156281. Epub 2017 Aug 2. Am J Clin Nutr. 2017. PMID: 28768654 Free article. Clinical Trial.
Calpain-10 interacts with plasma saturated fatty acid concentrations to influence insulin resistance in individuals with the metabolic syndrome.
Perez-Martinez P, Delgado-Lista J, Garcia-Rios A, Ferguson JF, Gulseth HL, Williams CM, Karlström B, Kieć-Wilk B, Blaak EE, Helal O, Małczewska-Malec M, Defoort C, Risérus U, Saris WH, Lovegrove JA, Drevon CA, Roche HM, Lopez-Miranda J. Perez-Martinez P, et al. Among authors: saris wh. Am J Clin Nutr. 2011 May;93(5):1136-41. doi: 10.3945/ajcn.110.010512. Epub 2011 Mar 9. Am J Clin Nutr. 2011. PMID: 21389182 Free article. Clinical Trial.
Effects of dietary fat modification on insulin sensitivity and on other risk factors of the metabolic syndrome--LIPGENE: a European randomized dietary intervention study.
Tierney AC, McMonagle J, Shaw DI, Gulseth HL, Helal O, Saris WH, Paniagua JA, Gołąbek-Leszczyñska I, Defoort C, Williams CM, Karsltröm B, Vessby B, Dembinska-Kiec A, López-Miranda J, Blaak EE, Drevon CA, Gibney MJ, Lovegrove JA, Roche HM. Tierney AC, et al. Among authors: saris wh. Int J Obes (Lond). 2011 Jun;35(6):800-9. doi: 10.1038/ijo.2010.209. Epub 2010 Oct 12. Int J Obes (Lond). 2011. PMID: 20938439 Clinical Trial.
Fasting and postprandial remnant-like particle cholesterol concentrations in obese participants are associated with plasma triglycerides, insulin resistance, and body fat distribution.
van Hees AM, Saris WH, Dallinga-Thie GM, Hul GB, Martinez JA, Oppert JM, Stich V, Astrup A, Arner P, Sørensen TI, Blaak EE. van Hees AM, et al. Among authors: saris wh. J Nutr. 2008 Dec;138(12):2399-405. doi: 10.3945/jn.108.094516. J Nutr. 2008. PMID: 19022964 Free article. Clinical Trial.
567 results